Narrowband ultraviolet B exposures maintain vitamin D levels during winter: A randomized controlled trial

Acta Dermato-Venereologica

Volumn 96, Issue 4, 2016, Pages 490-493

  Karppinen, Toni ^a,b   Ala Houhala, Meri ^a,b   Ylianttila, Lasse ^c   Kautiainen, Hannu ^d   Viljakainen, Heli ^e   Reunala, Timo ^a   Snellman, Erna ^a,b  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

^c STUK RADIATION AND NUCLEAR SAFETY AUTHORITY   (Finland)

^d HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^e UNIVERSITY OF HELSINKI AND HELSINKI UNIVERSITY HOSPITAL   (Finland)

Author keywords

25 hydroxyvitamin D; Body mass index; Narrow band ultraviolet B; Ultraviolet B

Indexed keywords

25 HYDROXYVITAMIN D; PARATHYROID HORMONE; VITAMIN D; 25-HYDROXYVITAMIN D; BIOLOGICAL MARKER;

ADULT; ARTICLE; BODY MASS; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; HUMAN EXPERIMENT; MALE; NARROWBAND ULTRAVIOLET B; NORMAL HUMAN; PRIORITY JOURNAL; RADIATION EXPOSURE; RANDOMIZED CONTROLLED TRIAL; SEASONAL VARIATION; SUMMER; ULTRAVIOLET B RADIATION; VITAMIN BLOOD LEVEL; VITAMIN INTAKE; WINTER; ADVERSE EFFECTS; ANALOGS AND DERIVATIVES; BLOOD; FINLAND; MIDDLE AGED; PROCEDURES; RADIATION DOSE; SEASON; TIME FACTOR; TREATMENT OUTCOME; ULTRAVIOLET PHOTOTHERAPY; ULTRAVIOLET RADIATION; UPREGULATION; VITAMIN D DEFICIENCY; YOUNG ADULT;

ADULT; BIOMARKERS; BODY MASS INDEX; FEMALE; FINLAND; HEALTHY VOLUNTEERS; HUMANS; MALE; MIDDLE AGED; RADIATION DOSAGE; SEASONS; TIME FACTORS; TREATMENT OUTCOME; ULTRAVIOLET RAYS; ULTRAVIOLET THERAPY; UP-REGULATION; VITAMIN D; VITAMIN D DEFICIENCY; YOUNG ADULT;

EID: 84976873355     PISSN: 00015555     EISSN: 16512057     Source Type: Journal    
DOI: 10.2340/00015555-2269     Document Type: Article

References (35)

1. Wacker M, Holick MF. Sunlight and vitamin D: a global perspective for health. Dermatoendocrinol 2013; 5: 51-108.
2. Holick MF. The cutaneous photosynthesis of previtamin D3: a unique photoendocrine system. J Invest Dermatol 1981; 77: 51-58.
3. Holick MF. Vitamin D: the underappreciated D-lightful hormone that is important for skeletal and cellular health. Curr Opin Endocrinol Diabetes Obes 2002; 9: 87-98.
4. Saneei P, Salehi-Abargouei A, Esmaillzadeh A. Serum 25-hydroxyvitamin D levels in relation to body mass index: a systematic review and meta-analysis. Obes Rev 2013; 14: 393-404.
5. Parker J, Hashmi O, Dutton D, Mavrodaris A, Stranges S, Kandala NB, et al. Levels of vitamin D and cardiometabolic disorders: systematic review and meta-analysis. Maturitas 2010; 65: 225-236.
6. Autier P, Boniol M, Pizot C, Mullie P. Vitamin D status and ill health: a systematic review. Lancet Diabetes Endocrinol 2014; 2: 76-89.
7. Institute of Medicine. Dietary reference intakes for calcium and vitamin D. Washington, DC: National Academies Press; 2011.
8. Vähävihu K, Ala-Houhala M, Peric M, Kautiainen H, Hasan T, Snellman E, et al. Narrowband ultraviolet B treatment improves vitamin D balance and alters antimicrobial peptide expression in skin lesions of psoriasis and atopic dermatitis. Br J Dermatol 2010; 163: 321-328.
9. Ala-Houhala MJ, Vähävihu K, Hasan T, Kautiainen H, Ylianttila L, Viljakainen HT. Comparison of narrowband ultraviolet B exposure and oral vitamin D substitution on serum 25-hydroxyvitamin D concentration. Br J Dermatol 2012; 167: 160-164.
10. Bogh MKB, Gullstrand J, Svensson A, Ljunggren B, Dorkhan M. Narrowband ultraviolet B three times per week is more effective in treating vitamin D deficiency than 1600 IU oral vitamin D3 per day: a randomized clinical trial. Br J Dermatol 2012; 167: 625-630.
11. Bogh MKB, Schmedes AV, Philipsen PA, Thieden E, Wulf HC. A small suberythemal ultraviolet B dose every second week is sufficient to maintain summer vitamin D levels: a randomized controlled trial. Br J Dermatol 2012; 166: 430-433.
12. Picot E, Meunier L, Picot-Debeze MC, Peyron JL, Meynadier J. Treatment of psoriasis with a 311-nm UVB lamp. Br J Dermatol 1992; 127: 509-512.
13. Almutawa F, Alnomair N, Wang Y, Hamzavi I, Lim HW. Systematic review of UV-based therapy for psoriasis. Am J Clin Dermatol 2013; 14: 87-109.
14. Boullion R, Eisman J, Garabedian M et al. Action spectrum for the production of pre-vitamin D in human skin. Available from: ftp://ftp.pmodwrc.ch/pub/roger/20080423163250.pdf. Commission Internationale de l'Eclairage (CIE) 2006; 174: 1-12.
15. Fitzpatrick TB. The validity and practicality of sun-reactive skin types I through VI. Arch Dermatol 1988; 124: 869-871.
16. Commission Internationale de l'E'clairage (CIE) (1999) Erythemal reference action spectrum and standard erythemal dose. CIE standard ISO 17166:1999(E) CIE S 007/E 1998.
17. Ylianttila L, Visuri R, Huurto L, Jokela K. Evaluation of a single-monochromator diode array spectroradiometer for sunbed UV-radiation measurements. Photochem Photobiol 2005; 81: 333-341.
18. Ylianttila L, Huurto L, Visuri R, Jokela K. Development of quality assurance methods for ultraviolet phototherapy devices. Available from: http://www.fimea.fi/documents/ 160140/753095/19694_julkaisut_4_2005_UV_julkaisu_ verkko_v2-rd.pdf.pdf. Finnish Medicines Agency. Publication series 4/2005. (in Finnish).
19. Thieden E, Philipsen P, Heydenreich J, Wulf HC. UV radiation exposure related to age, sex, occupation, and sun behavior based on time-stamped personal dosimeter readings. Arch Dermatol 2004; 140: 197-203.
20. Tsiaras W, Weinstock M. Factors influencing vitamin D status. Acta Derm Venereol 2011; 91: 115-124.
21. Matthews YJ, Halliday GM, Phan TA, Damian DL. Wavelength dependency for UVA-induced suppression of recall immunity in humans. J Dermatol Sci 2010; 59: 192-197.
22. Matthews YJ, Halliday GM, Phan TA, Damian DL. A UVB wavelength dependency for local suppression of recall immunity in humans demonstrates a peak at 300 nm. J Invest Dermatol 2010; 130: 1680-1684.
23. Fourtanier A, Moyal D, Maccario J, Compan D, Wolf P, Quehenberger F, et al. Measurement of sunscreen immune protection factors in humans: a consensus paper. J Invest Dermatol 2005; 125: 403-409.
24. Wolf P, Hoffmann C, Quehenberger F, Grinschgl S, Kerl H. Immune protection factors of chemical sunscreens measured in the local contact hypersensitivity model in humans. J Invest Dermatol 2003; 121: 1080-1087.
25. Hearn RM, Kerr AC, Rahim KF, Ferguson J, Dawe RS. Incidence of skin cancers in 3867 patients treated with narrow-band ultraviolet B phototherapy. Br J Dermatol 2008; 159: 931-935.
26. Tjioe M, Smits T, van de Kerkhof PC, Gerritsen MJ. The differential effect of broad band vs narrow band UVB with respect to photodamage and cutaneous inflammation. Exp Dermatol 2003; 12: 729-733.
27. Dawe RS. There are no 'safe exposure limits' for phototherapy. Br J Dermatol 2010; 163: 209-210.
28. Snellman E, Strozyk M, Segerbäck D, Klimenko T, Hemminki K. Effect of spectral range of the UV lamp on production of cyclobutane pyrimidine dimers in human skin in situ. Photodermatol Photoimmunol Photomed 2003; 19: 281-286.
29. Drinic A, Armas L, Van Dienst E, Heaney R. Volumetric dilution, rather than sequestration best explains the low vitamin D status of obesity. Obesity 2012; 20: 1444-1448.
30. Helldan A, Kosonen M, Tapanainen H, Raulio S, Mannisto S, Virtanen S. The National FINDIET 2012 Survey Helsinki National Institute for Health and Welfare 2013 Report No 16/2013. Available from: https://www.julkari. fi/handle/10024/110839 [accessed 2015 Jan 5].
31. [Finnish Nutrition Recommendations 2014. The National Nutrition Council.] [Accessed 2015 Mar 29]. Available from: http://www.ravitsemusneuvottelukunta.fi/files/attachments/ fi/vrn/ravitsemussuositukset_2014_fi_web.pdf (in Finnish).
32. Ala-Houhala MJ, Karppinen T, Vähävihu K, Kautiainen H, Dombrowski Y, Snellman E, et al. Narrow-band ultraviolet B treatment boosts serum 25-hydroxyvitamin D in patients with psoriasis on oral vitamin D supplementation. Acta Derm Venereol 2014; 94: 146-151.
33. Lagunova Z, Porojnicu AC, Aksnes L, Holick MF, Iani V, Bruland OS, et al. Effect of vitamin D supplementation and ultraviolet B exposure on serum 25-hydroxyvitamin D concentrations in healthy volunteers: a randomized, crossover clinical trial. Br J Dermatol 2013; 169: 434-440.
34. Wolf P. Oral vitamin D supplementation vs. ultraviolet B exposure: what is appropriate to achieve a sufficient vitamin D level? Br J Dermatol 2013; 169: 239.
35. Volmer DA, Mendes LR, Stokes CS. Analysis of vitamin D metabolic markers by mass spectrometry: current techniques, limitations of the "gold standard" method, and anticipated future directions. Mass Spectrom Rev 2015; 34: 2-23.